Skip to main content

Table 2 Frequency of mutations within PR

From: Five-year follow up of genotypic resistance patterns in HIV-1 subtype C infected patients in Botswana after failure of thymidine analogue-based regimens

Mutations

Frequency (%)

*P value

 

Group 1

Group 2

 

L10F/I

23

37

0.23

K20R/T/I/M

34.6

60

0.07

D30N

19.2

25.7

0.43

E35D/N

50

60

0.31

K45Q

3.8

17.14

0.12

M46I

7.7

20

0.19

D60E

23

34.28

0.43

Q61E/D

19

42.8

0.06

I62V

0

11.4

0.11

N88D

11.5

8.6

0.48

N88S

7.7

11.4

0.51

L89M

57.7

57.1

0.51

L89I

19.2

14.3

0.39

L90M

15

28

0.34

  1. * P value: probability of significant differences between groups